BofA raised the firm’s price target on Corpay (CPAY) to $379 from $377 and keeps a Buy rating on the shares. While Q1 revenue was a touch short of expectations, revenue guidance ex-Gringo and the midpoint of EPS was reiterated and the firm views guidance, sales momentum, and M&A transactions positively, the analyst tells investors. Corpay characterized the M&A pipeline as “very active,” notes the firm, which is “encouraged” by Corpay’s “repositioning toward a more corporate payments oriented company,” adds the analyst.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CPAY:
- Corpay price target lowered to $365 from $400 at UBS
- AvidXchange price target lowered to $10 from $12 at Baird
- Corpay price target lowered to $414 from $417 at Raymond James
- Corpay Inc: Positioned for Growth with Strategic Partnerships and Enhanced Revenue Channels
- Corpay, Inc. Reports Strong Q1 2025 Results